Merck CEO talks medicines beyond the company's top cancer drug
- Posted on January 14, 2025
- By CNBC
- 1 Views
Merck CEO talks medicines beyond the company's top cancer drug
Merck CEO Rob Davis told CNBC's Jim Cramer that there's more to the pharmaceutical giant than its lucrative cancer drug, Keytruda.
